Table 5 Relative expression of... | American Society of Hematology

Table 5

Relative expression of nucleoside transporters hENT1, hENT2, and hCNT3 in patient samples

Patient ID	Best response	Expression relative to normal PBMCs, 2^{−ΔΔ^Ct} (range)
Patient ID	Best response	hENT1	hENT2	hCNT3
39	PR	0.019 (0.014-0.025)	0.03 (0.02-0.04)	0.067 (0.42-0.1)
42	NE	0.056 (0.044-0.072)	0.009 (0.005-0.017)	N/E
45	SD	9.91 (7.04-13.96)	0.14 (0.03-0.065)	2.42 (0.25-23.67)
50 (baseline)	PR	0.10 (0.09-0.12)	0.67 (0.3-1.5)	0.063 (0.01-0.33)
At relapse		0.43 (0.28-0.65)	0.23 (0.15-0.37)	0.98 (0.15-6.5)
Normal PBMCs		1.00 (0.76-1.32)	1.00 (0.66-1.5)	1.00 (0.22-4.47)

Patient ID	Best response	Expression relative to normal PBMCs, 2^{−ΔΔ^Ct} (range)
Patient ID	Best response	hENT1	hENT2	hCNT3
39	PR	0.019 (0.014-0.025)	0.03 (0.02-0.04)	0.067 (0.42-0.1)
42	NE	0.056 (0.044-0.072)	0.009 (0.005-0.017)	N/E
45	SD	9.91 (7.04-13.96)	0.14 (0.03-0.065)	2.42 (0.25-23.67)
50 (baseline)	PR	0.10 (0.09-0.12)	0.67 (0.3-1.5)	0.063 (0.01-0.33)
At relapse		0.43 (0.28-0.65)	0.23 (0.15-0.37)	0.98 (0.15-6.5)
Normal PBMCs		1.00 (0.76-1.32)	1.00 (0.66-1.5)	1.00 (0.22-4.47)

hENT indicates human equilibrative nucleoside transporter; PR, partial remission; NE, not evaluable, N/E, not expressed; and SD, stable disease.